S
Seer Medical
Creating technology that revolutionizes the diagnosis and management of neurological conditions, with a special focus on epilepsy
About Seer Medical
Seer Medical is an innovative healthcare company specializing in home-based video EEG and ECG monitoring services, primarily targeting epilepsy diagnostics. Operating in the Australian market, Seer Medical serves patients, caregivers, and healthcare providers by offering a convenient and effective alternative to traditional hospital-based diagnostic methods. The company's business model revolves around providing advanced diagnostic tools and comprehensive support programs, which include instructional programs, coaching, skill-building guides, and ongoing technical support. Seer Medical generates revenue through its diagnostic services, which have already helped over 15,000 Australians achieve accurate diagnoses, thereby accelerating their path to effective condition management. By shifting diagnostic care from hospitals to homes, Seer Medical has freed up significant hospital resources, contributing to more efficient healthcare delivery. The company leverages cutting-edge research, clinical and engineering expertise, and cloud computing to enhance the quality of patient care and provide deep clinical insights. Seer Medical's vision is to revolutionize healthcare by making world-class clinical monitoring accessible and patient-centric, ultimately giving people more control over their health and time.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Melbourne, Australia
- Employees
- 99
- Open positions
- None listed
- Dealroom signal
- 63.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Neurology, Epilepsy, Health Diagnostics, Spinout, DT and LS, science-based
- Technology
- Artificial Intelligence, Hardware, Big Data
- Business model
- Manufacturing
- Client focus
- B2B, B2C
- Investment activity
- 1 company, latest Mar 2022
- Capital deployed
- $10M
- Preferred round
- EARLY VC
News
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Apr 2025 | $26M | $104M | Cadwell Laboratories · Breakthrough Victoria | ↗ |
| FundingOther financing | Jul 2022 | $0 | — | Breakthrough Victoria | ↗ |
Growth signals
Latest recorded traffic for Seer Medical is 6.7K monthly website visits, up 9.8% over the last three months. Seer Medical's team declined 1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Cochlear
Giant Leap Fund
SG Hiscock
Cadwell Laboratories
Breakthrough Victoria
Other known investors1 additional known investor
University of Melbourne
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Seer Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Seer Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.